VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 34 | -39.3% | 0.00% | – |
| Q4 2017 | $1,000 | – | 56 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -100.0% | 56 | -99.8% | 0.00% | -100.0% |
| Q3 2015 | $5,708,000 | -33.3% | 32,000 | -16.9% | 0.04% | -26.0% |
| Q2 2015 | $8,552,000 | -14.7% | 38,500 | -23.8% | 0.05% | -13.8% |
| Q1 2015 | $10,030,000 | +15.8% | 50,500 | -16.5% | 0.06% | +18.4% |
| Q4 2014 | $8,658,000 | -29.0% | 60,500 | -34.9% | 0.05% | -31.0% |
| Q3 2014 | $12,188,000 | -57.7% | 92,900 | -59.3% | 0.07% | -61.0% |
| Q2 2014 | $28,780,000 | +67.3% | 228,200 | +74.9% | 0.18% | +61.1% |
| Q1 2014 | $17,203,000 | -30.9% | 130,500 | -38.5% | 0.11% | -31.5% |
| Q4 2013 | $24,892,000 | – | 212,031 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |